170877 ⎘
Detection or diagnosis of diseases; Genitourinary disorders Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
ESTIMATING GLOMERULAR FILTRATION RATES IN FELINES
#2NOVEL POINT OF CARE SYSTEM AND METHOD USED FOR THE SAME
#3DIAGNOSING AND TREATING END-STAGE RENAL DISEASE (ESRD) IN OBESE SUBJECTS
#4EARLY STAGE DETECTION OF PERITONITIS
#5Chronic kidney disease detection
#6MARKERS FOR RENAL DISEASE
#7MASS SPECTROMETRIC ANALYSIS OF BIOMARKERS
#8CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS
#9METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#10METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF
#11HUMAN ANTI-HUMAN PLA2R ANTIBODY STANDARD SUBSTANCE AND USE THEREOF
#12SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#13METHOD FOR TESTING TERTIARY LYMPHOID TISSUE, AND KIT FOR TESTING TERTIARY LYMPHOID TISSUE
#14PRECISION MEDICINE FOR TREATMENT OF KIDNEY FUNCTION DECLINE
#15METHODS FOR TREATING ACUTE KIDNEY INJURY
#16BIOMARKER COMPOSITION FOR EARLY DIAGNOSIS OF KIDNEY DISEASES, AND METHOD FOR PROVIDING INFORMATION REQUIRED FOR EARLY DIAGNOSIS OF KIDNEY DISEASES BY USING SAME
#17METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING PERSISTENT ACUTE KIDNEY INJURY BASED ON C-C MOTIF CHEMOKINE LIGAND 14 MEASUREMENT
#18Methods for Detecting Renal Disease
#19MICROFLUIDIC URINE ALBUMIN/CREATININE CHIP (uACR-CHIP) FOR CHRONIC KIDNEY DISEASE EVALUATION
#20DETECTION OF KLOTHO
#21USE OF MMP19 AS BIOMARKER RELATED TO EARLY KIDNEY INJURY IN EARLY DIAGNOSIS OF KIDNEY INJURY
#22PREDICTION AND TREATMENT OF FAST PROGRESSING RENAL DISEASE
#23PAPER-BASED MICROFLUIDIC CHIP FOR MEASUREMENT OF CYSTATIN C IN PLASMA AND SERUM (CYS-C PAPER CHIP)
#24METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#25NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL DECLINE
#26AFUCOSYLATION OF HLA-SPECIFIC IGG1 AS A POTENTIAL PREDICTOR OF ANTIBODY PATHOGENICITY IN KIDNEY TRANSPLANTATION
#27Methods and Applications of Analyzing the Perfusate of an Ex Situ Perfused Kidney
#28Methods for Detecting Renal Disease
#29ANALOGS AND CONJUGATES OF ß-AMINOISOBUTYRIC ACID (BAIB)
#30LG3 Assay
#31METHOD FOR DETERMINATION OF MUTATED FORM OF MUCIN-1 PROTEIN IN A BIOLOGICAL SAMPLE
#32COMPOSITIONS AND METHODS FOR DIAGNOSIS, TREATMENT OF AND PREVENTION OF KIDNEY DISEASE
#33System for Detection, Monitoring, and Treatment of Kidney Disease
#34COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING CHRONIC KIDNEY DISEASE
#35GLOMERULONEPHRITIS BIOMARKERS
#36METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER
#37URINARY BIOMARKERS FOR ACTIVE LUPUS NEPHRITIS AND METHODS OF USE THEREOF
#38METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS
#39COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING KIDNEY INJURY
#40METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#41METHOD FOR ESTIMATING THE PROBABILITY OF MALADAPTIVE GLOMERULAR IMPAIRMENT IN KIDNEY DISEASES
#42METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#43NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
#44METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER
#45BIOMARKER FOR DETECTING TUBULOINTERSTITIAL DISORDER AND USE THEREOF
#46PROPHYLACTIC OR THERAPEUTIC AGENT FOR ACUTE RENAL FAILURE
#47Renal Insufficiency Prediction and Uses Thereof
#48Cilia Protein as Biomarkers and Methods of Use
#49Homogenous Immunoassay with Compensation for Background Signal
#50METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#51METHOD FOR EXAMINING PROGRESSION OF CHRONIC KIDNEY DISEASE IN SUBJECT, AND KIT
#52Markers for renal disease
#53Methods of Identifying Active Lupus Nephritis Flare
#54THERAPEUTIC USES OF DULAGLUTIDE
#55METHODS OF DIAGNOSING AND PREDICTING RENAL DECLINE
#56METHOD OF DETERMINING PROGNOSIS OF CHRONIC KIDNEY DISEASE
#57BIOMARKERS OF RENAL INJURY
#58HUMORAL ANTIBODY BIOMARKER FOR DETECTING ARTERY LESIONS, AND DETECTING CEREBROVASCULAR AND CARDIOVASCULAR DISORDER, DIABETES, CHRONIC NEPHROPATHY, OR SOLID CANCER
#59END STAGE RENAL DISEASE BIOMARKER PANEL
#60Danegaptide for Use in the Treatment or Prevention of a Kidney Disease
#61Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
#62NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF
#63PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#64KIDNEY FUNCTION BIOMARKERS
#65Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#66Kit comprising antibody binding acrolein-protein conjugate for diagnosing nephropathy
#67METHODS AND COMPOSITIONS FOR TREATMENT OF RENAL INJURY AND RENAL FAILURE
#68AUTOANTIBODIES RELATED TO IGA NEPHROPATHY
#69MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#70MARKER FOR ASSISTING IN DIAGNOSIS OF NEPHROTIC SYNDROME AND USE THEREOF
#71METHOD FOR SCREENING A SUBJECT FOR THE RISK OF CHRONIC KIDNEY DISEASE
#72Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereof
#73METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#74METHODS FOR IDENTIFYING AND TREATING ANTIBODY-MEDIATED ACQUIRED PRIMARY OR RECURRENT IDIOPATHIC NEPHROTIC SYNDROME
#75METHODS OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE
#76FOCAL ADHESION COMPLEX PROTEINS AS A DIAGNOSTIC MARKER FOR PODOCYTOPHATHIES
#77PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#78TEST STRIPS FOR DETERMINATION OF UREA LEVELS IN SALIVA AND FOR DETECTION OF AZOTEMIA OR KIDNEY DISEASE IN FELINE AND CANINE SUBJECTS
#79DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE IN A FELINE
#80KIT FOR DETECTING ANTI-PROTEASOME SUBUNIT ALPHA TYPE 1-IMMUNOGLOBULIN G (IgG) ANTIBODY
#81KIT FOR DETECTING ANTI-VINCULIN-IMMUNOGLOBULIN G (IgG) ANTIBODY
#82Methods of treating patients at risk for renal injury and renal failure
#83METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#84PREDICTION AND EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY
#85METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE
#86ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOF
#87COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE
#88COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE
#89PROFILING OF IMMUNODOMINANT PLA2R1 EPITOPES AS A PROGNOSIS AND PREDECTIVE FACTOR IN MEMBRANOUS NEPHROPATHY
#90Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#91A SYNTHENTIC POLY-TRANSTHYRETIN AFFINITY TRAP FOR DETECTING AMYLOIDOGENIC TRANSTHYRETIN FORMS IN PLASMA SAMPLES OFTRANTHYRETIN AMYLOIDOSIS PATIENTS
#92KIDNEY HEALTH MONITORING IN HYPERTENSION PATIENTS
#93METHOD OF DIFFERENTIATING OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY, METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOP ATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
#94Identifying Feline Renal Risk Factors and Compositions and Methods for Improving Feline Health
#95Markers for renal disease
#96METHOD OF SCREENING FOR A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY METHOD OF MONITORING A RESPONSE TO TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY IN A SUBJECT AND A METHOD OF TREATMENT OF A CHRONIC KIDNEY DISEASE OR GLOMERULOPATHY
#97Biomarkers of membranous glomerulonephritis
#98METHOD FOR PREDICTING THE RISK OF INCIDENCE OF CHRONIC KIDNEY DISEASE
#99COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE
#100Noninvasive method to quantify kidney function and functional decline
#101NEW PROTEIN MARKERS OF RENAL DAMAGE
#102Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#103METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION
#104Methods and compositions for evaluation and treatment of renal injury and renal failure based on C-C motif chemokine ligand 14 measurement
#105METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#106Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#107METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY
#108METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#109Methods of preparing a biofluid sample for detection of kidney injury
#110Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers
#111Systems and Methods for Machine Learning-based Identification of Acute Kidney Injury in Trauma Surgery and Burned Patients
#112MONITORING OF NEUROMODULATION USING BIOMARKERS
#113A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS
#114C3/C5 CONVERTASE ASSAYS
#115MOUSE MONOCLONAL ANTIBODIES AGAINST GALACTOSE-DEFICIENT IGA1,PREPARATION METHOD THEREOF, AND USE THEREOF
#116METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#117Biomarkers of fast progression of chronic kidney disease
#118METHOD FOR ASSISTING EVALUATION OF CONDITION OF KIDNEYS, SYSTEM FOR EVALUATING CONDITION OF KIDNEYS, AND PROGRAM FOR EVALUATING CONDITION OF KIDNEYS
#119EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#120Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#121METHODS FOR EVALUATION AND TREATMENT OF RENAL INJURY BASED ON C-C MOTIF CHEMOKINE LIGAND 14 MEASUREMENT
#122USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS
#123Use of engineered renal tissues in assays
#124Method and reagents for diagnosing Membranous Nephropathy
#125Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#126METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES
#127DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#128INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE
#129METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#130USE OF NATRIURETIC PEPTIDES TO ASSESS AND TREAT ACUTE KIDNEY INJURY
#131RENAL CLEARABLE NANOPARTICLES AS EXOGENOUS MARKERS FOR EVALUATING KIDNEY FUNCTION
#132METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#133Methods for Detecting Renal Disease
#134Method for acquiring information on respiratory infection
#135Urine metabolomics based method of detecting renal allograft injury
#136METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#137Molecular renal probes for detecting acute kidney injury
#138Methods and systems for LC-MS/MS proteomic genotyping
#139NANOPARTICLE PROBES AND METHODS OF MAKING AND USE THEREOF
#140USE OF SHROOM3 IN CHRONIC KIDNEY DISEASE AND CHRONIC ALLOGRAFT NEPHROPATHY
#141USE OF AMNIOTIC FLUID PEPTIDES FOR PREDICTING POSTNATAL RENAL FUNCTION IN CONGENITAL ANOMALIES OF THE KIDNEY AND THE URINARY TRACT
#142Reagents for detecting Alu elements in cell-free DNA (cfDNA)
#143Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#144CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS
#145KIDNEY DISEASE PROGNOSIS PREDICTION METHOD AND SYSTEM
#146Compositions and methods for diagnosing and/or treating kidney injury
#147Biomarker of polycystic kidney disease and uses thereof
#148Noninvasive method to quantify kidney function and functional decline
#149Glomerulonephritis biomarkers
#150METHOD FOR DETERMINING GLOMERULAR FILTRATION ABILITY
#151Calibrator, complex, and method for measuring IgA aggregate
#152MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#153METHOD AND KIT FOR DETERMINING POSSIBILITY OF ONSET OF IGA NEPHROPATHY
#154Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#155METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION
#156Rapid quantitative test to diagnose polycystic kidney disease
#157BIOMARKERS AND TEST MODELS FOR CHRONIC KIDNEY DISEASE
#158Passive mixing microfluidic urinary albumin chip (UAL-chip) for chronic kidney disease
#159BIOMARKERS AND CLASSIFICATION ALGORITHMS FOR CHRONIC KIDNEY DISEASE IN CATS
#160Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#161Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
#162Methods and materials for identifying and treating membranous nephropathy
#163BIOMARKER, METHODS, AND COMPOSITIONS THEREOF FOR EVALUATION OR MANAGEMENT OF KIDNEY FUNCTION OR DIAGNOSING OR AID IN DIAGNOSING KIDNEY DYSFUNCTION OR KIDNEY DISEASE
#164Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#165ANALOGS AND CONJUGATES OF BETA-AMINOISOBUTYRIC ACID (BAIB)
#166Compositions and methods for detecting and/or treating inflammation
#167METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#168COMPLEMENT ALTERNATIVE PATHWAY-ASSOCIATED NEPHROPATHY BIOMARKERS
#169PROTEIN BIOMARKERS FOR NEPHROPATHY AND APPLICATIONS THEREOF
#170ICOSL for use as a Renal Therapeutic
#171Methods for diagnosing and assessing risk of developing glomerulosclerosis
#172METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF
#173METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#174METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#175Urine sample testing apparatus and apparatus for processing measurement results of urine sample
#176LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#177Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy
#178METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH NEPHROTOXICITY
#179METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH KIDNEY TRANSPLANTATION
#180METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION FOLLOWING CARDIAC PROCEDURES OR EVENTS
#181Determination method and kit for determining possibility of reduced renal function
#182Compositions and Methods for Preventing or Treating Nephrolithiasis
#183METHODS FOR PREVENTING ACUTE KIDNEY INJURY
#184Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#185Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
#186Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#187Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#188Nanovesicles derived from bacteria of genus and use thereof
#189Transcutaneous organ function measurement
#190METHOD FOR DETERMINING THE ANTIOXIDANT CAPACITY OF A BIOLOGICAL SAMPLE AND RELATED KIT
#191USE OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 AND TISSUE INHIBITOR OF METALLOPROTEINASE 2 IN THE MANAGEMENT OF RENAL REPLACEMENT THERAPY
#192Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#193METHOD FOR THE DIAGNOSIS OF C3NEF-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
#194BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#195Homogenous immunoassay with compensation for background signal
#196Biomarker sampling in the context of neuromodulation devices, systems, and methods
#197METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#198SCREENING METHOD FOR BLOOD IgA PRODUCTION INHIBITOR OR FOR PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST DISEASES CAUSED BY EXCESSIVE IgA IN BLOOD
#199Methods for determining DPP3 and therapeutic methods
#200MODIFICATION TO STAGING GUIDELINES FOR IMPROVED ACUTE KIDNEY INJURY (AKI) RECOVERY DETECTION
#201Treating Renal and Liver Dysfunction with TLR4 Antagonists
#202Antibodies that specifically bind alpha klotho
#203METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#204Prognosis and progression biomarkers for chronic kidney disease
#205Identification and monitoring of apoptosis inhibitor of macrophage
#206Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#207Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#208BIOMARKERS FOR PREDICTING PROGNOSIS OF KIDNEY DISEASE
#209ASSAYS FOR IGFBP7 HAVING IMPROVED PERFORMANCE IN BIOLOGICAL SAMPLES
#210Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
#211GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#212COMPOSITIONS COMPRISING LIGANDS TO RHOB PROTEIN AND THE USES THEREOF
#213Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers
#214A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNTION
#215ANALYTICAL AND THERAPEUTIC METHODS AND COMPOSITIONS, AND USES THEREOF
#216METHOD AND APPARATUS FOR DETERMINING INTERSTITIAL VOLUME
#217Methods of diagnosing and treating chronic kidney disease
#218Biomarkers of renal injury
#219Compositions and Methods for Assessing Acute Kidney Injury (AKI) and Mortality Risk
#220DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#221Non-Glycosylated suPar Biomarkers and Uses Thereof
#222BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
#223Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#224DNA origami nanostructures for treatment of acute kidney injury
#225BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#226Methods of diagnosing and predicting renal disease
#227SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#228Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#229USE OF SERUM 2-CYSTEINE PEROXIREDOXINS (2-CYS-PRDX) AS BIOMARKERS OF CHRONIC KIDNEY DISEASES
#230Nanoparticle probes and methods of making and use thereof
#231Methods and compositions for treating and diagnosing autoimmune diseases
#232Methods of treating patients at risk for renal injury and renal failure
#233Markers for renal disease
#234NANOPARTICLE-ENHANCED ENZYMATIC IMMUNE BIOSENSOR ASSAY FOR ANTIGEN DETECTION
#235Diagnostic tool to determine podocyte foot process effacement
#236Exosome-mediated diagnosis of human immunodeficiency virus infection
#237Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#238Hough transform-based vascular network disorder features on baseline fluorescein angiography scans predict response to anti-VEGF therapy in diabetic macular edema
#239TRPC6 involved in glomerulonephritis
#240URINE FLOW CYTOMETRY AS BIOMARKER OF RENAL DISEASES
#241Use of engineered renal tissues in assays
#242METHOD FOR CALCULATING GLOMERULAR FILTRATION RATE (GFR)
#243Compositions and methods for detecting and/or treating inflammation
#244USE OF ANTI-UCHL1 IGG PLASMA CONCENTRATION FOR DIAGNOSING IDIOPATHIC STEROID SENSITIVE NEPHROTIC SYNDROME
#245Method for creating a renal injury model to screen molecules for the treatment of renal injury
#246Identifying drug candidates for treating polycystic kidney disease using organoids generated from primary cells
#247Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#248Methods and systems for LC-MS/MS proteomic genotyping
#249Preventive or therapeutic agent for kidney disease
#250Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#251Exosome-mediated diagnosis of hepatitis virus infections and diseases
#252PREDICTION OF KIDNEY DISEASE PROGRESSION USING HOMOARGININE AS A BIOMARKER
#253Methods for diagnosing risk of renal allograft fibrosis and rejection
#254Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
#255Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy
#256MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE
#257MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE
#258MOLECULAR MARKER AND KIT FOR EARLY DIAGNOSIS AND PREDICTION OF SEPSIS ACUTE KIDNEY INJURY AND APPLICATION THEREOF
#259Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#260Kidney disease prognosis prediction method and system
#261METHODS FOR THE USE OF GALECTIN 3 BINDING PROTEIN DETECTED IN THE URINE FOR MONITORING THE SEVERITY AND PROGRESSION OF LUPUS NEPHRITIS
#262Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
#263Biomarker SBP1 for early diagnosis of kidney diseases, and use thereof
#264System and method for differential diagnosis of diseases
#265Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#266Compositions and methods for diagnosing and/or treating kidney injury
#267METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#268METHODS FOR DIAGNOSING AND TREATING NEPHROTIC SYNDROME
#269METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID
#270Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure
#271Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#272MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#273Compositions and methods for treating and preventing end stage renal disease
#274HISTONES AND/OR PROADM AS MARKERS INDICATING ORGAN DYSFUNCTION
#275Method of treating extracellular tissue and vascular calcification and arteriosclerosis
#276Diagnostic Test to Exclude Significant Renal Injury
#277Method for preparing and analyzing fluorescent compounds in plasma
#278Compounds, reagents, and uses thereof
#279Nucleic acids encoding antibodies with high affinity for Alpha-Klotho
#280INHIBITING CHRONIC BLOOD AND NEPHROLOGICAL DISORDERS USING LYSINE-BASED SUPPLEMENTS
#281Inhibiting chronic blood and nephrological disorders using lysine-based supplements
#282Inhibiting chronic blood and nephrological disorders using lysine-based supplements
#283Method and treating renal disease
#284METHODS FOR EVALUATING RENAL INJURY AND RENAL FAILURE USING URINE LEVELS OF CHITINASE-3-LIKE PROTEIN 1
#285Method for Identifying an Agent for Treating Abnormal Kidney Function
#286SIGNAL BIOMARKERS
#287Niacinamide (NAM) in ischemic tissue injury
#288Methods of treating volume depletion and kidney injury
#289Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#290Antibodies which specifically bind αKlotho polypeptide
#291RENAL FUNCTION EVALUATING DEVICE, DEVICE FOR PREDICTING ONSET OF KIDNEY DISEASE COMPLICATIONS, AND PHOSPHOROUS INGESTION AMOUNT ESTIMATING DEVICE
#292Compositions and methods for detecting, treating and preventing diseases and disorders
#293Methods for Early Diagnosis of Kidney Disease
#294HEALTH MONITORING SYSTEM, HEALTH MONITORING METHOD, AND HEALTH MONITORING PROGRAM
#295METHODS AND KITS FOR PREDICTING THE RISK OF RELAPSE IN PATIENTS SUFFERING FROM IDIOPATHIC NEPHROTIC SYNDROME
#296Methods and kits for monitoring membranous nephropathy
#297Sensors for detecting citrate, and method of detecting citrate using the same
#298Methods and Compositions For the Treatment of Proteinuric Diseases
#299Biomarker of polycystic kidney disease and uses thereof
#300Marker for determining diabetic nephropathy